Previous close | 31.88 |
Open | 31.88 |
Bid | 32.66 x 200 |
Ask | 32.71 x 400 |
Day's range | 31.88 - 32.76 |
52-week range | 29.44 - 44.95 |
Volume | |
Avg. volume | 829,146 |
Market cap | 3.143B |
Beta (5Y monthly) | 1.48 |
PE ratio (TTM) | 52.74 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
The organizations will host an event with Canada’s leading providers, employers, and fertility advocates to show support for the millions in need of family building careNEW YORK, April 17, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, and Fertility Matters Canada, a national fertility patient-focused organization, today announced both organizations will be co-hosting an event to garner support for increas
The leading benefits solution and largest infertility advocacy non-profit will host a series of events aimed at raising awareness for the millions of individuals facing family building challengesNEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, and RESOLVE: The National Infertility Association today announced a series of nationwide events to commemorate National Infertility Awareness Week
NEW YORK, March 18, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that Pete Anevski, Progyny’s Chief Executive Officer, and Mark Livingston, Chief Financial Officer, will participate in a virtual fireside chat at the KeyBanc Life Sciences & MedTech Investor Forum on Tuesday, March 19, 2024, at 1:30 P.M. Eastern Time. A live audiocast and replay will be available from the Events and Present